A little dose goes a long way.
CaPP3’s results show that taking as little as 75 to 100mg of aspirin each day can halve the risk of bowel cancer in people with Lynch syndrome, a heritable genetic condition that makes bowel cancer much more likely. The findings mean regulators and doctors should soon be able to recommend a specific low-dose aspirin prescription for people with Lynch syndrome, protecting many more of them from bowel cancer.
